SSTR2 and neoplasm: In contrast, patients with gastro-entero-pancreatic tumours have been treated successfully with somatostatin analogues [22,23]; furthermore, exogenous gene transfer of the SSTR2 gene into SSTR-negative tumours has enabled treatment with somatostatin analogues [24].